Paper212144
Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.
Lutzner MA. Bull Cancer, 1978. Cited by 186 papers, by iCite.
Cite this record
ConductScience Library. Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Papers, record 212144. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/212144
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Skin Neoplasms | Major topic |
| Warts | Major topic |
| Adolescent | |
| Adult | |
| Carcinoma in Situ | |
| Carcinoma, Squamous Cell | |
| Child | |
| Child, Preschool | |
| DNA Repair | |
| Female | |
| Genes, Recessive | |
| Humans | |
| Immunity, Cellular | |
| Infant | |
| Infant, Newborn | |
| Intellectual Disability | |
| Male | |
| Papillomaviridae | |
| Precancerous Conditions | |
| Syndrome | |
| Time Factors |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38869286 | Deficiency in Ever2 does not increase susceptibility of mice to pathogenesis by the mouse papillomavirus, MmuPV1. | J Virol | 2024 | https://conductscience.org/library/papers/38869286 | PubMed |
| 37877723 | HPV38 impairs UV-induced transcriptional activation of the IL-18 pro-inflammatory cytokine. | mSphere | 2023 | https://conductscience.org/library/papers/37877723 | PubMed |
| 34522745 | Epidermodysplasia verruciformis in Mohs micrographic surgery. | JAAD Case Rep | 2021 | https://conductscience.org/library/papers/34522745 | PubMed |
| 31626329 | Verrucous pilar cysts infected with beta human papillomavirus. | J Cutan Pathol | 2020 | https://conductscience.org/library/papers/31626329 | PubMed |
| 31121434 | Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. | Curr Opin Immunol | 2019 | https://conductscience.org/library/papers/31121434 | PubMed |
| 30955489 | Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance. | Philos Trans R Soc Lond B Biol Sci | 2019 | https://conductscience.org/library/papers/30955489 | PubMed |
| 29946305 | Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29946305 | PubMed |
| 29660489 | Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer. | Papillomavirus Res | 2018 | https://conductscience.org/library/papers/29660489 | PubMed |
| 27279814 | The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients. | Postepy Dermatol Alergol | 2016 | https://conductscience.org/library/papers/27279814 | PubMed |
| 25987895 | Role of human papillomaviruses in carcinogenesis. | Ecancermedicalscience | 2015 | https://conductscience.org/library/papers/25987895 | PubMed |
| 25347116 | The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study. | J Invest Dermatol | 2015 | https://conductscience.org/library/papers/25347116 | PubMed |
| 23363696 | Epidermodysplasia verruciformis in an HIV-infected man: a case report and review of the literature. | Top Antivir Med | 2012 | https://conductscience.org/library/papers/23363696 | PubMed |
| 23036745 | Warts and all: human papillomavirus in primary immunodeficiencies. | J Allergy Clin Immunol | 2012 | https://conductscience.org/library/papers/23036745 | PubMed |
| 22903682 | EVER2 deficiency is associated with mild T-cell abnormalities. | J Clin Immunol | 2013 | https://conductscience.org/library/papers/22903682 | PubMed |
| 22850876 | Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22850876 | PubMed |
| 20824263 | [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream]. | Hautarzt | 2010 | https://conductscience.org/library/papers/20824263 | PubMed |
| 19706093 | Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. | Pediatr Dermatol | 2009 | https://conductscience.org/library/papers/19706093 | PubMed |
| 19487731 | The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. | Microbiol Mol Biol Rev | 2009 | https://conductscience.org/library/papers/19487731 | PubMed |
| 9836487 | Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9836487 | PubMed |
| 8543590 | Roots and perspectives of contemporary papillomavirus research. | J Cancer Res Clin Oncol | 1996 | https://conductscience.org/library/papers/8543590 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/212144
GET https://conductscience.org/api/papers/v1/212144/cited_by?page=2